Philip James Wealth Mangement’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100,796
Closed -$604K 161
2026
Q1
$604K Sell
100,796
-128,434
-56% -$966K 0.07% 103
2025
Q4
$1.64M Sell
229,230
-214,942
-48% -$1.7M 0.19% 74
2025
Q3
$4.74M Sell
444,172
-433,665
-49% -$4.26M 0.55% 42
2025
Q2
$8.5M Sell
877,837
-7,468
-0.8% -$77K 1.08% 18
2025
Q1
$13.2M Buy
885,305
+14,702
+2% +$226K 1.6% 9
2024
Q4
$13M Buy
870,603
+66,341
+8% +$1.08M 1.68% 8
2024
Q3
$15.4M Buy
+804,262
New +$16.7M 1.89% 8

Other funds holding OGN

Philip James Wealth Mangement's OGN Position: Q2 2026 in Review

Philip James Wealth Mangement sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 100,796 shares — an estimated $604K sold.

Philip James Wealth Mangement first reported a position in OGN in Q3 2024 and held it in 7 quarters. The position peaked at $15.4M in Q3 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Philip James Wealth Mangement reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Philip James Wealth Mangement sold 100,796 Organon & Co shares in Q2 2026, an estimated $604K.
  • Philip James Wealth Mangement first reported a position in Organon & Co in Q3 2024 and held it in 7 quarters.
  • Philip James Wealth Mangement's Organon & Co position peaked at $15.4M in Q3 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.